Characteristics of Patients Presenting with New Symptoms Following Acute Coronavirus Disease-19 (COVID-19; N = 499)
| Patients | |
|---|---|
| n (%) | |
| Sex | |
| Male | 213 (42.7) |
| Female | 286 (57.3) |
| Age, years | |
| Estimated Mean ± SD | 56.1 ± 16.6 |
| 18 to 32 | 49 (9.8) |
| 33 to 47 | 109 (21.8) |
| 48 to 62 | 154 (30.9) |
| 63 to 77 | 132 (26.5) |
| ≥78 | 55 (11.0) |
| Race | |
| White | 240 (48.1) |
| Black | 110 (22.0) |
| Asian | 11 (2.2) |
| Other* | 112 (22.5) |
| Unknown | 26 (5.2) |
| Ethnicity | |
| Hispanic | 157 (31.5) |
| Non-Hispanic | 316 (63.3) |
| Unknown | 26 (5.2) |
| Acute COVID-19 | |
| Hospitalized | 243 (48.7) |
| Intensive Care Unit | 31 (6.2) |
| Intubation | 25 (5.0) |
| Dialysis | 14 (2.8) |
| Treatment (Dexamethasone or Remdesivir) | 25 (5.0) |
| ≥ 1 Primary Care Visits | 174 (34.9) |
| Telemedicine | 151 (30.3) |
| Post-Acute COVID-19 Primary Care Visits† | |
| 1 | 361 (72.4) |
| 2 | 76 (15.2) |
| ≥ 3 | 62 (12.4) |
| Pre-existing Conditions | |
| Hypertension | 262 (52.5) |
| Diabetes | 134 (26.9) |
| Obesity | 103 (20.6) |
| Asthma | 85 (17.0) |
| COPD | 42 (8.4) |
| HIV Infection | 6 (1.2) |
COPD, chronic obstructive pulmonary disease; ICD-10-CM, International Classification of Disease, Tenth Version, Clinical Modification; HIV, human immunodeficiency virus; PCR, polymerase chain reaction; SD, standard deviation.
↵* Other race includes American Indian or Alaska Native, Other Pacific Islander, or unspecified Other race by patient report.
↵† Number of COVID-19 related primary care visits for a new symptom (defined by ICD-10-CM codes which do not appear during the patient's lookback and first appear between 15 days and 9 months after the patient's first positive SARS-CoV-2 PCR test).